1. Home
  2. DUOT vs CRBP Comparison

DUOT vs CRBP Comparison

Compare DUOT & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • CRBP
  • Stock Information
  • Founded
  • DUOT 1990
  • CRBP 2009
  • Country
  • DUOT United States
  • CRBP United States
  • Employees
  • DUOT N/A
  • CRBP N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • CRBP Health Care
  • Exchange
  • DUOT Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • DUOT 180.9M
  • CRBP 210.8M
  • IPO Year
  • DUOT N/A
  • CRBP N/A
  • Fundamental
  • Price
  • DUOT $9.87
  • CRBP $11.91
  • Analyst Decision
  • DUOT Strong Buy
  • CRBP Strong Buy
  • Analyst Count
  • DUOT 2
  • CRBP 9
  • Target Price
  • DUOT $12.75
  • CRBP $48.38
  • AVG Volume (30 Days)
  • DUOT 340.7K
  • CRBP 537.1K
  • Earning Date
  • DUOT 11-12-2025
  • CRBP 11-12-2025
  • Dividend Yield
  • DUOT N/A
  • CRBP N/A
  • EPS Growth
  • DUOT N/A
  • CRBP N/A
  • EPS
  • DUOT N/A
  • CRBP N/A
  • Revenue
  • DUOT $19,026,308.00
  • CRBP N/A
  • Revenue This Year
  • DUOT $292.26
  • CRBP N/A
  • Revenue Next Year
  • DUOT $43.21
  • CRBP $220.00
  • P/E Ratio
  • DUOT N/A
  • CRBP N/A
  • Revenue Growth
  • DUOT 159.00
  • CRBP N/A
  • 52 Week Low
  • DUOT $3.84
  • CRBP $4.64
  • 52 Week High
  • DUOT $11.23
  • CRBP $20.56
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 57.43
  • CRBP 44.86
  • Support Level
  • DUOT $8.10
  • CRBP $11.06
  • Resistance Level
  • DUOT $9.53
  • CRBP $12.43
  • Average True Range (ATR)
  • DUOT 0.79
  • CRBP 0.72
  • MACD
  • DUOT -0.01
  • CRBP 0.10
  • Stochastic Oscillator
  • DUOT 68.94
  • CRBP 77.87

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: